Literature DB >> 8320931

Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure.

A Davenport1, E J Will, A M Davison.   

Abstract

The mortality of patients with combined acute hepatic and renal failure remains high. Previous studies have reported both patient morbidity and mortality directly attributable to the use of extracorporeal circuits used to treat renal failure. We investigated the effect of various modes of renal replacement therapy in 30 consecutive patients referred with both fulminant hepatic and acute renal failure. Cardiac output decreased during the first hour of 30 intermittent machine haemofiltration treatments, by 15 +/- 3%, as did tissue oxygen delivery, 16 +/- 3% and tissue oxygen uptake, 13 +/- 4%, whereas there was no significant change during 30 continuous hemofiltration and/or dialysis treatments. Intracranial pressure remained stable during the continuous modes but increased from 9 +/- 2 mm Hg to 17 +/- 2 mm Hg, P < 0.01, during intermittent machine hemofiltration, with the greatest increase of 55 +/- 9% within the first hour. Mean arterial blood pressure was stable during treatment with the continuous modes, but decreased by 20 +/- 3% during the first hour of intermittent machine hemofiltration, resulting in a maximum reduction in cerebral perfusion pressure of 35 +/- 8%. In this group of critically ill patients continuous modes of renal replacement therapy resulted in superior cardiac and intracranial stability compared to standard intermittent modes of treatment.

Entities:  

Mesh:

Year:  1993        PMID: 8320931

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  26 in total

Review 1.  Artificial and bioartificial support systems for liver failure.

Authors:  J P Liu; L L Gluud; B Als-Nielsen; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 2.  [Hepatorenal syndrome].

Authors:  I Kürer; A Sommerer; G Puhl; U Kaisers; W Boemke
Journal:  Anaesthesist       Date:  2006-01       Impact factor: 1.041

Review 3.  Renal replacement therapies: physiological review.

Authors:  Claudio Ronco; Zaccaria Ricci
Journal:  Intensive Care Med       Date:  2008-09-13       Impact factor: 17.440

Review 4.  Extracorporeal liver support.

Authors:  Jan Stange
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

5.  Continuous Venous-Venous-Hemodialysis versus Intermittent-Hemodialysis in Critically Ill Patients.

Authors:  Juan Jose Olivero
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Apr-Jun

Review 6.  Acute kidney injury in acute on chronic liver failure.

Authors:  Rakhi Maiwall; S K Sarin; Richard Moreau
Journal:  Hepatol Int       Date:  2015-10-15       Impact factor: 6.047

7.  [Acute renal failure. Extracorporeal therapy].

Authors:  J T Kielstein; D Fliser
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

8.  Use of High-Flow Continuous Renal Replacement Therapy with Citrate Anticoagulation to Control Intracranial Pressure by Maintaining Hypernatremia in a Patient with Acute Brain Injury and Renal Failure.

Authors:  Joshua E Medow; Shalin R Sanghvi; R Michael Hofmann
Journal:  Clin Med Res       Date:  2014-12-08

9.  Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure.

Authors:  Kazuhiro Kotoh; Munechika Enjoji; Makoto Nakamuta; Tsuyoshi Yoshimoto; Motoyuki Kohjima; Shusuke Morizono; Shinsaku Yamashita; Yuki Horikawa; Kengo Yoshimitsu; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

10.  Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.

Authors:  Filipe S Cardoso; Michelle Gottfried; Shannan Tujios; Jody C Olson; Constantine J Karvellas
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.